Virtis Bio Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 10 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 56.33%
(FY 2020)
- Profit -41.50%
(FY 2020)
- Ebitda -158.20%
(FY 2020)
- Net Worth -88.65%
(FY 2020)
- Total Assets -25.56%
(FY 2020)
About Virtis Bio Labs
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Azhakiamanavalan Devasenapathy and Perumal Shilpa serve as directors at the Company.
- CIN/LLPIN
U85195TZ2015PTC021034
- Company No.
021034
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Virtis Bio Labs Private Limited offer?
Virtis Bio Labs Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Floor Cleaner, Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Virtis Bio Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Azhakiamanavalan Devasenapathy  | Managing Director | 12-Jan-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Perumal Shilpa | Whole-Time Director | 12-Jan-2015 | Current |
Financial Performance of Virtis Bio Labs.
Virtis Bio Labs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 56.33% increase. The company also saw a substantial fall in profitability, with a 41.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 88.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Virtis Bio Labs?
In 2017, Virtis Bio Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Virtis Bio Labs?
Unlock and access historical data on people associated with Virtis Bio Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Virtis Bio Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Virtis Bio Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
